- Community-Beiträge
- Aktuellste Threads
| Geld/Brief | 92,82 $ / 159,69 $ |
| Spread | +72,04% |
| Schluss Vortag | 140,91 $ |
| Gehandelte Stücke | 302.567 |
| Tagesvolumen Vortag | 34.115.606 $ |
| Tagestief - Tageshoch - | |
| 52W-Tief 50,52 $ 52W-Hoch 141,08 $ | |
| Jahrestief 77,705 $ Jahreshoch 141,08 $ | |
| Umsatz in Mio. | 46,02 $ |
| Operatives Ergebnis (EBIT) in Mio. | -158,13 $ |
| Jahresüberschuss in Mio. | -130,15 $ |
| Umsatz je Aktie | 0,72 $ |
| Gewinn je Aktie | -2,05 $ |
| Gewinnrendite | -282,83% |
| Umsatzrendite | -282,83% |
| Return on Investment | -19,43% |
| Marktkapitalisierung in Mio. | 8.452 $ |
| KGV (Kurs/Gewinn) | -42,60 |
| KBV (Kurs/Buchwert) | 9,03 |
| KUV (Kurs/Umsatz) | 121,31 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +91,76% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 131,75 $ | - | - | 16.07.26 | |
| Nasdaq | 140,91 $ | 0 % | 140,91 $ | 17.07.26 | |
| NYSE | 140,93 $ | +7,04% | 131,665 $ | 17.07.26 | |
| Tradegate | 118,00 € | -4,84% | 124,00 € | 16.07.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 17.07.26 | 140,91 | 34,1 M |
| 16.07.26 | 132,02 | 6,27 M |
| 15.07.26 | 135,46 | 8,47 M |
| 14.07.26 | 131,27 | 5,73 M |
| 13.07.26 | 129,89 | 5,03 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 131,42 $ | +7,22% |
| 1 Monat | 111,44 $ | +26,44% |
| 6 Monate | 81,99 $ | +71,86% |
| 1 Jahr | 56,44 $ | +149,66% |
| 5 Jahre | 45,82 $ | +207,53% |
| Marktkapitalisierung | 8,45 Mrd. $ |
| Streubesitz | 81,62% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +15,48% | BlackRock Inc |
| +9,92% | Farallon Capital Management, L.L.C. |
| +9,25% | RTW INVESTMENTS, LLC |
| +7,01% | Vanguard Group Inc |
| +5,93% | iShares Core S&P Small-Cap ETF |
| +5,41% | Vanguard Portfolio Management, LLC |
| +5,22% | Deep Track Capital, LP |
| +5,16% | Bvf Inc |
| +5,16% | State Street Corp |
| +4,36% | Vanguard Capital Management, LLC |
| +4,02% | UBS Group AG |
| +3,94% | Johnson & Johnson |
| +3,12% | Vanguard Total Stock Mkt Idx Inv |
| +2,32% | Geode Capital Management, LLC |
| +2,25% | iShares Russell 2000 ETF |
| +1,77% | Citadel Advisors Llc |
| +1,76% | Adage Capital Partners Gp LLC |
| +1,73% | HHG PLC |
| +1,73% | Perceptive Advisors LLC |
| +1,73% | COMMODORE CAPITAL LP |
| +1,72% | State Street® SPDR® S&P® Biotech ETF |
| +1,72% | Driehaus Capital Management LLC |
| +1,70% | Marshall Wace Asset Management Ltd |
| +1,67% | Jennison Associates LLC |
| +1,67% | Vanguard Health Care Inv |
| +1,67% | Wellington Management Company LLP |
| +1,58% | SPDR® S&P Biotech ETF |
| +1,57% | Amvescap Plc. |
| +1,52% | Woodline Partners LP |
| +1,52% | ADAR1 Capital Management LLC |
| +1,51% | The Goldman Sachs Group Inc |
| +1,51% | T. Rowe Price Associates, Inc. |
| +1,42% | T. Rowe Price Health Sciences |
| +1,40% | Morgan Stanley - Brokerage Accounts |
| +1,37% | Bank of America Corp |
| +1,32% | Jefferies Financial Group Inc |
| +1,29% | Hood River Capital Management LLC |
| +1,29% | Vanguard Small Cap Growth Index Inv |
| +1,11% | Vanguard Small Cap Index |
| +1,07% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,94% | Fidelity Small Cap Index |
| +0,90% | Pictet Asset Manangement SA |
| +0,88% | SPDR® Portfolio S&P 600™ Sm Cap ETF |
| +0,86% | iShares S&P Small-Cap 600 Growth ETF |
| +0,85% | State Street SPDR Port S&P 600 Sm CpETF |
| +0,82% | Janus Henderson Triton D |
| +0,82% | Janus Henderson US SMID Cap Growth |
| +0,82% | iShares Russell 2000 Growth ETF |
| +0,77% | Fidelity Select Biotechnology |
| +0,70% | Invesco Discovery A |
| +0,70% | Invesco OFI Small Cap Growth |
| +0,69% | Hood River Small-Cap Growth Instl |
| +0,67% | Invesco S&P SmallCap Momentum ETF |
| +0,66% | apo Medical Opportunities R |
| +0,66% | Vanguard Tax-Managed Small Cap Adm |
| +0,65% | BlackRock Health Sciences Opps Inv A |
| +0,60% | American Century U.S. Small Cap Growth |
| +0,60% | American Century Small Cap Growth Inv |
| +0,56% | iShares Biotechnology ETF |
| +0,55% | Pictet-Biotech P USD |
| +0,54% | Fidelity Extended Market Index |
| +0,48% | SPDR® S&P 600 Small Cap Growth ETF |
| +0,47% | Schwab US Small-Cap ETF™ |
| +119,48% | Institutionelle Aktionäre |
| +81,62% | Streubesitz |
| -37,86% | Individuelle Aktionäre |
Angeblich laufen hier Übernahmegespräche mit J&J
100 Mio. $ Offering
https://feeds.issuerdirect.com/news-release.html?newsid=8739441983893046
positive FRONTIER1 Phase 2b Studienergebnisse JNJ-2113 / PN-235 (Psoriasis)
https://feeds.issuerdirect.com/news-release.html?newsid=6598557738756234
https://endpts.com/despite-mid-stage-plaque-psoriasis-win-jj-appears-uncertain-on-partners-il-23-drug/
